EU Medical Device Regulation
(MDR 2017/745)

EU MDR (Regulation (EU) 2017/745) is the legal framework governing the safety, performance and market access of medical devices sold in the European Union. It entered into force on 25 May 2017 and became applicable on 26 May 2021, replacing the Medical Device Directive (93/42/EEC) and the Active Implantable Medical Devices Directive (90/385/EEC).

As a regulation rather than a directive, it applies directly and identically across every EU member state, with no room for local interpretation. It introduced stronger clinical evidence requirements, standardised technical documentation, EU-wide device traceability through UDI and EUDAMED, and continuous post-market surveillance rather than one-time approval. It also requires every manufacturer to have a named Person Responsible for Regulatory Compliance (PRRC).

Who Needs to Comply?

EU MDR assigns distinct obligations across the supply chain:

• Manufacturers: full regulatory responsibility for design, documentation, QMS and clinical evaluation.
• Authorised Representatives: required for non-EU manufacturers; act as the EU contact and share liability.
• Importers: verify CE marking and the Authorised Representative appointment before market entry.
• Distributors: verify CE marking, labelling and storage conditions.
• Notified Bodies: independent bodies that assess conformity for all Class IIa, IIb and III devices, and for certain Class I devices.

EU MDR Device Classification

Risk classification under Annex VIII determines your regulatory pathway:

• Class I: lowest risk; mostly self-declared, with limited Notified Body review for sterile devices, devices with a measuring function and reusable surgical instruments.
• Class IIa: low-to-medium risk; Notified Body assessment required.
• Class IIb: medium-to-high risk; Notified Body assessment required.
• Class III: highest risk, including many implantable devices; the most rigorous assessment route.

Classification determines both the depth of documentation required and whether a Notified Body is involved at all.

Key EU MDR Requirements

Requirements scale with device class and typically include General Safety and Performance Requirements (GSPR), risk management, technical documentation, clinical evaluation, a Quality Management System, post-market surveillance, vigilance reporting, UDI and EUDAMED registration, labelling and Instructions for Use, a named PRRC, and conformity assessment leading to CE marking.

Explore EU MDR Topics in Depth

• Technical Files: what belongs in your EU MDR technical documentation under Annex II and III.
• Risk Management (ISO 14971): building a compliant medical device risk management file.
• Labelling: EU MDR labelling and UDI marking requirements.
• Guides on IFU, Clinical Evaluation, PMS, GSPR and ISO Standards are coming soon.

Common EU MDR Compliance Challenges

Manufacturers most often run into:

• Classification carried over from older MDD assessments without review.
• Gaps in technical documentation.
• Insufficient clinical evidence.
• Limited Notified Body capacity and long review queues.
• Transition deadlines for legacy MDD devices, which run to 31 December 2027 for Class III and Class IIb implantable devices and to 31 December 2028 for other classes, subject to conditions.
• Mandatory EUDAMED registration, which applies from 28 May 2026 for actor, UDI/device, certificate and market surveillance modules.
• Treating post-market surveillance as a one-time report rather than a continuous process.

EU MDR Consulting Services

At 3i Concept, we specialise in expert EU MDR consulting for businesses filing with a Notified Body under Regulation (EU) 2017/745. Our services include:

• Regulatory Strategy Development: tailored advice so your product meets EU MDR requirements and gets approved without unnecessary delays.
• Documentation and Submission Support: preparing technical documentation and filing submissions to Notified Bodies.
• Compliance Gap Analysis: in-depth review of your existing processes against current EU MDR requirements.
• Risk Management Support: structured risk identification, evaluation and control, aligned with ISO 14971.
• QMS Development and Support: aligning your quality processes with MDR and ISO 13485 requirements.
• CE Marking Support: guiding you through conformity assessment, the Declaration of Conformity and CE marking.
• Combination Product Support: Article 117 Notified Body Opinions and device documentation for integral drug-device products.
• Testing and Performance Support: evaluating device performance characteristics as part of your technical file.
• Audit Readiness Planning: preparing your organisation for internal and external audits.
• Ongoing Support and Monitoring: continuous guidance throughout your device’s lifecycle to sustain compliance.

Partner with 3i Concept to streamline your path to market and confidently meet EU MDR requirements, while you focus on innovation and bringing your products to patients.

Why Choose 3i Concept

Our EU MDR consulting work is led by Subhash Meena, a Medical Device and Drug-Device Combination Product expert with 13+ years of experience. He has worked across Meril Life Sciences, Sun Pharmaceutical Industries, Amneal Pharmaceuticals and Dr. Reddy’s Laboratories, spanning cardiology, orthopaedics and endosurgery.

His experience includes combination products such as pen injectors, auto-injectors and prefilled syringes, with direct Notified Body and USFDA filing experience. For manufacturers in India and worldwide, that means an EU MDR consultant who has done the work from inside the industry.